Insider · CIK 0001532218

Patel Sanj K

Reports to the SEC for 5 companies · LONDON

sec.gov

Transactions

Companies

Filings

CIK

0001532218

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-01	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	+9,991 sh	—	—	86,165
2026-09-01	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	+6,481 sh	—	—	92,646
2026-09-01	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	+6,237 sh	—	—	98,883
2026-09-01	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	+8,609 sh	—	—	107,492
2026-09-01	KNSAKiniksa Pharmaceuticals International, plcF Tax Payment	Director, CHAIRMAN & CEO	FTax Payment	−15.1K sh	$79.28	−$1.2M	92,348
2026-09-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitA Award	Director, CHAIRMAN & CEO	AAward	+30.1K sh	—	—	30,050
2026-09-01	KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award	Director, CHAIRMAN & CEO	AAward	+120K sh	—	—	120,150
2026-09-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	−8,609 sh	—	—	25,826
2026-09-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	−6,237 sh	—	—	12,475
2026-09-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	−6,481 sh	—	—	6,481
2026-09-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	−9,991 sh	—	—	0
2026-09-01	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	+9,991 sh	—	—	86,165
2026-09-01	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	+6,481 sh	—	—	92,646
2026-09-01	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	+6,237 sh	—	—	98,883
2026-09-01	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	+8,609 sh	—	—	107,492
2026-09-01	KNSAKiniksa Pharmaceuticals International, plcF Tax Payment	Director, CHAIRMAN & CEO	FTax Payment	−15.1K sh	$79.28	−$1.2M	92,348
2026-09-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitA Award	Director, CHAIRMAN & CEO	AAward	+30.1K sh	—	—	30,050
2026-09-01	KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award	Director, CHAIRMAN & CEO	AAward	+120K sh	—	—	120,150
2026-09-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	−8,609 sh	—	—	25,826
2026-09-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	−6,237 sh	—	—	12,475
2026-09-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	−6,481 sh	—	—	6,481
2026-09-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	−9,991 sh	—	—	0
2026-06-01	KNSAKiniksa Pharmaceuticals International, plcC Conversion	Director, CHAIRMAN & CEO	CConversion	+900K sh	—	—	951,794
2026-06-01	KNSAKiniksa Pharmaceuticals International, plc · Class B Ordinary SharesC Conversion	Director, CHAIRMAN & CEO	CConversion	−900K sh	—	—	626,160
2026-05-01	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	+48.6K sh	$30.93	+$1.5M	48,565
2026-05-01	KNSAKiniksa Pharmaceuticals International, plcS Sale	Director, CHAIRMAN & CEO	SSale	−48.6K sh	$54.02	−$2.62M	0
2026-05-01	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	−48.6K sh	—	—	0
2026-04-30	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	+2,141 sh	$30.93	+$66.2K	2,141
2026-04-30	KNSAKiniksa Pharmaceuticals International, plcS Sale	Director, CHAIRMAN & CEO	SSale	−2,141 sh	$54.01	−$116K	0
2026-04-30	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	−2,141 sh	—	—	48,565
2026-04-29	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	+22.5K sh	$30.93	+$697K	22,544
2026-04-29	KNSAKiniksa Pharmaceuticals International, plcS Sale	Director, CHAIRMAN & CEO	SSale	−22.5K sh	$54.01	−$1.22M	0
2026-04-29	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	−22.5K sh	—	—	50,706
2026-04-28	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	+432K sh	$10.36	+$4.47M	431,904
2026-04-28	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	+51.8K sh	$30.93	+$1.6M	483,654
2026-04-28	KNSAKiniksa Pharmaceuticals International, plcS Sale	Director, CHAIRMAN & CEO	SSale	−74.6K sh	$50.43	−$3.76M	409,019
2026-04-28	KNSAKiniksa Pharmaceuticals International, plcS Sale	Director, CHAIRMAN & CEO	SSale	−114K sh	$51.47	−$5.85M	295,346
2026-04-28	KNSAKiniksa Pharmaceuticals International, plcS Sale	Director, CHAIRMAN & CEO	SSale	−244K sh	$52.02	−$12.7M	51,750
2026-04-28	KNSAKiniksa Pharmaceuticals International, plcS Sale	Director, CHAIRMAN & CEO	SSale	−51.8K sh	$54.02	−$2.8M	0
2026-04-28	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	−432K sh	—	—	0
2026-04-28	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	−51.8K sh	—	—	73,250
2026-04-07	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	+9,991 sh	—	—	81,005
2026-04-07	KNSAKiniksa Pharmaceuticals International, plcF Tax Payment	Director, CHAIRMAN & CEO	FTax Payment	−4,831 sh	$48.94	−$236K	76,174
2026-04-07	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	−9,991 sh	—	—	0
2026-04-06	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	+7,278 sh	$10.36	+$75.4K	7,278
2026-04-06	KNSAKiniksa Pharmaceuticals International, plcS Sale	Director, CHAIRMAN & CEO	SSale	−7,278 sh	$50.01	−$364K	0
2026-04-06	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	−7,278 sh	—	—	431,904
2026-04-01	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director, CHAIRMAN & CEO	MExercise/Conversion	+21.3K sh	—	—	81,327
2026-04-01	KNSAKiniksa Pharmaceuticals International, plcF Tax Payment	Director, CHAIRMAN & CEO	FTax Payment	−10.3K sh	$48.13	−$496K	71,014
2026-04-01	KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award	Director, CHAIRMAN & CEO	AAward	+120K sh	—	—	120,150

Recent filings

Accepted (ET)
Sep 34
Patel Sanj K0001532218-26-000016
SEC(opens sec.gov)
Sep 34
Patel Sanj K0001532218-26-000014
SEC(opens sec.gov)

Companies

Address

C/O KINIKSA PHARMACEUTICALS INT'L 105 PICCADILLY, SECOND FLOOR

LONDON, W1J 7NJ